Saturday 17 October 2026 Export INDP’s income statement to Excel — free account

Indaptus Therapeutics, Inc.

INDP Healthcare Biotechnology

In the quarter to June 2026, EPS grew 99.8% and free cash flow grew 52.0%, each against the same quarter a year earlier.

2.63 0.22 −7.72%

Follow INDP

Alert me

Market cap: $437.7M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(317.98%)	(588.41%)	(931.79%)	(318.04%)
ROA Full definition →		(223.71%)	(250.45%)	(496.74%)	(163.84%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(401.16%)	(661.53%)	(1,511.15%)	(135.62%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(15.07)	(15.34)	(1.53)	(0.13)
Free Cash Flow Full definition →		(15.03)	(14.82)	(16.79)	(14.70)
Other line items
Cash ROIC Full definition →		(144.07%)	(127.14%)	(611.41%)	(64.10%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.89	0.71	0.89	0.95
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(15.07)	(15.34)	(1.53)	(0.13)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates